Trial intelligence / Profile preview

N-of-1 Trials of Blood Pressure Medications in Adults With Hypertension

NCT02744456Phase 1Completed

Sponsor
Columbia University
Start
Aug 2014
Primary completion
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of losartan, amlodipine and hydrochlorothiazide in hypertension (HTN), sponsored by Columbia University. Primary endpoint: Participants satisfied with participating in N-of-1 trial at 4 months. Started Aug 2014; status: completed.

02

Drugs

losartanamlodipinehydrochlorothiazide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02744456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02744456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call